Renal function in patients with heart failure: prognostic value

被引:19
作者
Casado, J. [1 ]
Montero, M. [2 ]
Formiga, F. [3 ]
Camafort, M. [4 ]
Sanchez, C. [5 ]
Muela, A. [6 ]
Diez, J. [7 ]
Perez, J. I. [8 ]
机构
[1] Hosp Henares, Med Interna Serv, Madrid, Spain
[2] Hosp Univ Reina Sofia, Med Interna Serv, Cordoba, Spain
[3] Hosp Univ Bellvitge, Med Interna Serv, Barcelona, Spain
[4] Hosp Comarcal Mora dEbre, Med Interna Serv, Tarragona, Spain
[5] Hosp Nuestra Senora Sonsoles, Med Interna Serv, Avila, Spain
[6] Hosp Leon, Med Interna Serv, Leon, Spain
[7] Hosp Royo Villanova, Med Interna Serv, Zaragoza, Spain
[8] Hosp Clin Univ Lozano Blesa, Med Interna Serv, Zaragoza, Spain
来源
REVISTA CLINICA ESPANOLA | 2012年 / 212卷 / 03期
关键词
Heart failure; Kidney function; Prognosis; CHRONIC KIDNEY-DISEASE; OUTCOMES; INSUFFICIENCY; DYSFUNCTION; PREVALENCE; GUIDELINES; ANEMIA; RISK;
D O I
10.1016/j.rce.2011.12.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Introduction: Impaired renal function can lead to a poor prognosis in patients with heart failure (HF). This study analyses the prevalence and prognostic value of impaired renal function in a cohort of patients with HE Methods: We analysed patients who were included in the RICA study (multicentre, prospective cohort study) who were admitted for decompensated HF in 52 Spanish Internal Medicine Departments between March 2008 and September 2009. The patients were grouped according to their renal function, evaluated by eGF, using the MDRD formula. Results: A total of 714 patients (54% women) with a mean age of 77.3+8.7 years were included. Of these, 84% had hypertension, and hypertensive heart disease was the most common aetiology of HF (39.2%). Ejection fraction was normal in 64.7% of patients, and 59.5% had an eGF less than 60 mL/min per 1.73 m(2), and 11.2% with an eGF less than 30 mL/min per 1.73 m(2). Less spironolactone was prescribed in patients with advanced stages of renal dysfunction (24%), compared with patients with an eGF>60 mL/min/1.73 m(2) (35%; P=.025). Worsening renal function was independently associated with an increased mortality risk (RR: 2.05; 95% CI: 1.13-3.71; P=.018). Conclusions: About 60% of patients admitted to Internal Medicine with HF have impaired renal function. This comorbidity is associated with a two-fold increase in all-cause mortality. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 30 条
[1]
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Adams, KF ;
Fonarow, GC ;
Emerman, CL ;
LeJemtel, TH ;
Costanzo, MR ;
Abraham, WT ;
Berkowitz, RL ;
Galvao, M ;
Horton, DP .
AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216
[2]
[Anonymous], 2008, REV ESP CARDIOL, DOI DOI 10.1157/13126044
[3]
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern? [J].
Bakris, GL ;
Weir, MR .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) :685-693
[4]
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease [J].
Berger, Alan K. ;
Duval, Sue ;
Manske, Connie ;
Vazquez, Gabriela ;
Barber, Cheryl ;
Miller, Leslie ;
Luepker, Russell V. .
AMERICAN HEART JOURNAL, 2007, 153 (06) :1064-1073
[5]
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure - The Rotterdam Study [J].
Bleumink, GS ;
Knetsch, AM ;
Sturkenboom, MCJM ;
Straus, SMJM ;
Hofman, A ;
Deckers, JW ;
Witteman, JCM ;
Stricker, BHC .
EUROPEAN HEART JOURNAL, 2004, 25 (18) :1614-1619
[6]
A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[7]
Cohen N, 2004, CLIN NEPHROL, V61, P177
[8]
Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) [J].
Cowie, MR ;
Komajda, M ;
Murray-Thomas, T ;
Underwood, J ;
Ticho, B .
EUROPEAN HEART JOURNAL, 2006, 27 (10) :1216-1222
[9]
The kidney in heart failure [J].
De Santo, NG ;
Cirillo, M ;
Perna, A ;
Pollastro, RM ;
Frangiosa, A ;
Di Stazio, E ;
Iorio, L ;
Di Leo, VA ;
Anastasio, P .
SEMINARS IN NEPHROLOGY, 2005, 25 (06) :404-407
[10]
Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis [J].
de Silva, R ;
Nikitin, NP ;
Witte, KKA ;
Rigby, AS ;
Goode, K ;
Bhandari, S ;
Clark, AL ;
Cleland, JGF .
EUROPEAN HEART JOURNAL, 2006, 27 (05) :569-581